Methodological items | Abulaiti 2022 | Catagni 2019 | Li 2020 | Liu 2020 | Yushan 2020 |
---|---|---|---|---|---|
A clearly stated aim | 2 | 2 | 2 | 2 | 2 |
Inclusion of consecutive patients | 2 | 2 | 2 | 2 | 2 |
Prospective collection of data | 0 | 0 | 0 | 1 | 0 |
Endpoints appropriate to the aim of the study | 2 | 2 | 2 | 2 | 2 |
Unbiased assessment of the study endpoint | 1 | 1 | 1 | 1 | 1 |
Follow-up period appropriate to the aim of the study | 2 | 2 | 1 | 2 | 2 |
Loss to follow-up less than 5% | 2 | 2 | 2 | 2 | 2 |
Prospective calculation of the study size | 0 | 1 | 0 | 0 | 0 |
An adequate control group | 1 | 1 | 1 | 1 | 1 |
Contemporary groups | 2 | 2 | 2 | 2 | 2 |
Baseline equivalence of groups | 1 | 2 | 2 | 2 | 1 |
Adequate statistical analyses | 1 | 2 | 1 | 2 | 1 |
Total score | 16 | 19 | 16 | 17 | 16 |